AI Summary
StalkCURI remains in a Stage 4 decline with confirmed lower highs and lower lows under declining EMAs. Short-term execution timing is neutral, lacking clear reversal signals at current support. The medium-term bias is bearish, favoring trimming exposure on any relief rallies into the EMA band. Optimal execution comes from rejection at the 9/20 EMA or 50 SMA resistance zone. A sustained break above and hold of the declining EMAs would invalidate the bearish posture.